0001127602-21-019043.txt : 20210603
0001127602-21-019043.hdr.sgml : 20210603
20210603172959
ACCESSION NUMBER: 0001127602-21-019043
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210601
FILED AS OF DATE: 20210603
DATE AS OF CHANGE: 20210603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Munsch Frederick
CENTRAL INDEX KEY: 0001864367
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 21993714
MAIL ADDRESS:
STREET 1: 400 SOMERSET CORPORATE BLVD.
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bausch Health Companies Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
DATE OF NAME CHANGE: 20100928
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
3
1
form3.xml
PRIMARY DOCUMENT
X0206
3
2021-06-01
0
0000885590
Bausch Health Companies Inc.
BHC
0001864367
Munsch Frederick
400 SOMERSET CORPORATE BLVD.
BRIDGEWATER
NJ
08807
1
SVP, Controller and CAO
Common Shares, No Par Value
21172
D
Non-Qualified Stock Options (right to purchase)
14.38
2027-03-01
Common Shares, No Par Value
8046
D
Non-Qualified Stock Options (right to purchase)
15.32
2028-03-07
Common Shares, No Par Value
12172
D
Non-Qualified Stock Options (right to purchase)
23.16
2029-02-27
Common Shares, No Par Value
8506
D
Non-Qualified Stock Options (right to purchase)
24.77
2030-02-26
Common Shares, No Par Value
11265
D
Non-Qualified Stock Options (right to purchase)
32.56
2031-03-03
Common Shares, No Par Value
6683
D
Includes 14,616 Restricted Share Units ("RSUs") which will vest, subject to the reporting person's continued service, as follows: (i) 891 RSUs on February 26, 2022; (ii) 974 RSUs on February 27, 2022; (iii) 892 RSUs on February 26, 2023; (iv) 5,322 RSUs granted on March 3, 2021 that will vest in equal installments on each of the first three anniversaries of the date of grant; and (v) 6,537 RSUs granted on May 3, 2021 that will vest in equal in equal installments on each of the first three anniversaries of the date of grant.
Vested RSUs are settled in Common Shares, no par value, of the Issuer.
Vests in equal installments on each of the first three anniversaries of the date of grant.
/s/ Kirsten O'Donnell, attorney-in-fact for Frederick Munsch
2021-06-03
EX-24
2
doc1.txt
POWER OF ATTORNEY (PUBLIC): MUNSCH POWER OF ATTORNEY
POWER OF ATTORNEY
Know all by these presents that the undersigned hereby constitutes and appoints
each of Christina Ackermann. Kelly Webber, D. Alexander Matheson, and
Kirsten O'Donnell, or any of them signing singly, and with full power
of substitution, the undersigned's true and lawful attorney-in-fact to:
(1) prepare, execute in the undersigned's name and on the undersigned's behalf,
and submit to the U.S. Securities and Exchange Commission (the "SEC") a
Form ID, including amendments thereto, and any other documents necessary or
appropriate to obtain codes and passwords enabling the undersigned to make
electronic filings with the SEC of reports required by Section 16(a) of the
Securities Exchange Act of 1934 (the "Exchange Act") or any rule or regulation
of the SEC;
(2) execute for and on behalf of the undersigned, in the undersigned's capacity
as a director and/or officer of Bausch Health Companies Inc.
(the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the
Exchange Act and the rules thereunder;
(3) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4, or 5,
complete and execute any amendment or amendments thereto, and timely file
such form with the SEC and any stock exchange or similar authority; and
(4) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit
to, in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney shall be in such form and
shall contain such terms and conditions as such attorney-in-fact may approve
in such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the
rights and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with
respect to the undersigned's holdings of and transactions in securities
issued by the Company, unless earlier revoked by the undersigned in a signed
writing delivered to the foregoing attorneys-in-fact.
[REMAINDER OF PAGE LEFT BLANK INTENTIONALY]
IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of this 20th day of May 2021.
By: /s/ Frederick Munsch
Name: Frederick Munsch